Literature DB >> 16122376

EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.

Ying-Xin Fan1, Lily Wong, Gibbes R Johnson.   

Abstract

We previously found that EGF (epidermal growth factor) increases the EGFR (EGF receptor) kinase-binding affinity towards the major tyrosine phosphorylation sites in downstream adaptor proteins such as Gab1 (Grb2-associated binding protein 1) and Shc [Src homology 2 (SH2) domain and collagen containing protein], but not that towards EGFR autophosphorylation sites [Fan, Wong, Deb and Johnson (2004) J. Biol. Chem. 279 , 38143-38150]. EGFR activation can also result in transphosphorylation of tyrosine resides in the C-terminal region of the related receptors ErbB2, ErbB3 and ErbB4 in heterodimers which are formed upon ligand stimulation. In the present study, we investigated the specificity of EGFR kinase by comparing the steady state kinetic parameters for peptides derived from all four ErbBs in the absence or presence of EGF. Our results demonstrated that (i) EGFR kinase can efficiently phosphorylate a broad range of diverse peptide sequences representing ErbB sites; (ii) certain ErbB2, ErbB3 and ErbB4 sites had higher specificity constants than any EGFR sequence and (iii) EGF stimulation consistently increases the k(cat) approx. 5-fold, but does not significantly alter the K(m) for any ErbB peptides. Furthermore, peptides containing lysine at position -2 or -3 N-terminal to the target tyrosine were found to be poor EGFR kinase substrates, and substitution of these lysines with glutamine decreased the K(m) and increased the k(cat) for these substrates. We conclude that EGFR kinase-mediated ErbB transphosphorylations are mostly controlled at the level of oligomerization, and not by a preference of the EGFR kinase for phosphorylation sites in any particular ErbB. The results also demonstrated that, unlike phosphorylation sites in select downstream targets, EGF does not regulate the recognition of phosphorylation sites in the C-terminal region of any of the ErbBs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122376      PMCID: PMC1316279          DOI: 10.1042/BJ20051122

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.

Authors:  C Sweeney; K L Carraway
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 3.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 4.  Receptor tyrosine kinase substrates: src homology domains and signal transduction.

Authors:  G Carpenter
Journal:  FASEB J       Date:  1992-11       Impact factor: 5.191

5.  Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.

Authors:  R R Beerli; N E Hynes
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

Review 6.  The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Authors:  Y Yarden
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

7.  Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor.

Authors:  D R Knighton; D L Cadena; J Zheng; L F Ten Eyck; S S Taylor; J M Sowadski; G N Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

8.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling.

Authors:  Z Songyang; K L Carraway; M J Eck; S C Harrison; R A Feldman; M Mohammadi; J Schlessinger; S R Hubbard; D P Smith; C Eng
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.

Authors:  D J Riese; Y Bermingham; T M van Raaij; S Buckley; G D Plowman; D F Stern
Journal:  Oncogene       Date:  1996-01-18       Impact factor: 9.867

10.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling.

Authors:  M Holgado-Madruga; D R Emlet; D K Moscatello; A K Godwin; A J Wong
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

View more
  13 in total

1.  Src defines a new pool of EGFR substrates.

Authors:  Nicole Michael; Natalia Jura
Journal:  Nat Struct Mol Biol       Date:  2015-12       Impact factor: 15.369

Review 2.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

3.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

4.  Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases.

Authors:  Qifang Xu; Kimberly L Malecka; Lauren Fink; E Joseph Jordan; Erin Duffy; Samuel Kolander; Jeffrey R Peterson; Roland L Dunbrack
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

5.  Activity assay of epidermal growth factor receptor tyrosine kinase inhibitors in triple-negative breast cancer cells using peptide-conjugated magnetic beads.

Authors:  Gargi Ghosh; Xiaoliang Yan; Stephen J Kron; Sean P Palecek
Journal:  Assay Drug Dev Technol       Date:  2012-09-20       Impact factor: 1.738

6.  Analytical reduction of combinatorial complexity arising from multiple protein modification sites.

Authors:  Marc R Birtwistle
Journal:  J R Soc Interface       Date:  2015-02-06       Impact factor: 4.118

7.  Computational delineation of tyrosyl-substrate recognition and catalytic landscapes by the epidermal growth factor receptor tyrosine kinase domain.

Authors:  Yingting Liu; Ravi Radhakrishnan
Journal:  Mol Biosyst       Date:  2014-04-29

8.  Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutants.

Authors:  Ying-Xin Fan; Lily Wong; Michael P Marino; Wu Ou; Yi Shen; Wen Jin Wu; Kwok-Kin Wong; Jakob Reiser; Gibbes R Johnson
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

Review 9.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

10.  A highly efficient peptide substrate for EGFR activates the kinase by inducing aggregation.

Authors:  Kate Engel; Tomoaki Sasaki; Qi Wang; John Kuriyan
Journal:  Biochem J       Date:  2013-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.